Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Coherus Biosimilar Used ‘Scientific Justification’ To Skip Switch Study, Still Get Interchangeability With Lucentis
Sep 02 2022
•
By
Sue Sutter
Cimerli was not subject to a 'switching' study prior to earning an interchangeability nod • Source: Shutterstock
More from Biosimilars
More from Products